- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Orum Therapeutics Inc (475830)
Orum Therapeutics Inc stock price live, this page displays KQ 475830 stock exchange data. View the 475830 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Orum Therapeutics Inc real time stock price chart below.
What Is the Orum Therapeutics Inc Stock Price Today?
The Orum Therapeutics Inc stock price today is 52,200.
What Is the Stock Symbol for Orum Therapeutics Inc?
The stock symbol for Orum Therapeutics Inc is "475830."
What Stock Exchange Does Orum Therapeutics Inc Trade On?
Orum Therapeutics Inc is listed and trades on the KOSDAQ stock exchange.
Is Orum Therapeutics Inc a Good Stock to Buy?
Determining whether Orum Therapeutics Inc, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 475830 quote. (ISIN: KR7475830006)
What Is the Orum Therapeutics Inc Stock Price Today?
The Orum Therapeutics Inc stock price today is 52,200.
What Is the Stock Symbol for Orum Therapeutics Inc?
The stock symbol for Orum Therapeutics Inc is "475830."
What Stock Exchange Does Orum Therapeutics Inc Trade On?
Orum Therapeutics Inc is listed and trades on the KOSDAQ stock exchange.
Is Orum Therapeutics Inc a Good Stock to Buy?
Determining whether Orum Therapeutics Inc, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 475830 quote. (ISIN: KR7475830006)
KOSDAQ
Currency in KRW
52,200
-900(-1.69%)
Closed·
Fair Value
An estimate of a Orum Therapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
48,950
54,100
52 wk Range
18,020
146,600
475830 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Orum Therapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
48,95054,100
52 wk Range
18,020146,600
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
475830 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Orum Therapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock generally trades with high price volatility
- Orum Therapeutics adds two directors to board
- Investing.com
- Orum Therapeutics adds two directors to board
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Earnings
Latest Release
May 15, 2026
EPS / Forecast
-676.67 / --
Revenue / Forecast
-- / --
Compare 475830 to Peers and Sector
Metrics to compare | 475830 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship475830PeersSector | |
|---|---|---|---|---|
P/E Ratio | −23.3x | −23.6x | −0.4x | |
PEG Ratio | 0.05 | −0.41 | 0.00 | |
Price/Book | 9.5x | 2.5x | 2.6x | |
Price / LTM Sales | 55,008.4x | 11.9x | 3.0x | |
Upside (Analyst Target) | - | 37.3% | 49.1% | |
Fair Value Upside | Unlock | 10.4% | 6.1% | Unlock |
Orum Therapeutics, Inc., a biopharmaceutical company, engages in the research and development of pharmaceuticals for cancer and immune diseases in South Korea and the United States. The company develops ORM-6151, which is in Phase I clinical trial for the treatment of acute myeloid leukemia and myelodysplastic syndromes; ORM-1153, which is in pre-clinical trial for the treatment of acute myeloid leukemia and hematologic malignancies; and ORM-1023, which is in pre-clinical trial for the treatment of small cell lung cancer and neuroendocrine tumor. It is also involved in the development of multiple programs for the treatment of solid tumors and immunology and inflammation; and E3 Ligase-DAC adaptor, an adaptor linker platform that conjugates protein degraders to antibodies and enables E3 ligase-based DACs. The company was founded in 2016 and is headquartered in Daejeon, South Korea.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Orum Therapeutics (475830) Stock Price Today?
The Orum Therapeutics stock price today is 52,200 KRW.
What Stock Exchange Does Orum Therapeutics Trade On?
Orum Therapeutics is listed and trades on the KOSDAQ.
What Is the Stock Symbol for Orum Therapeutics?
The stock symbol for Orum Therapeutics is "475830."
What Is the Orum Therapeutics Market Cap?
As of today, Orum Therapeutics market cap is 1.13T KRW.
What Is Orum Therapeutics's Earnings Per Share (TTM)?
The Orum Therapeutics EPS (TTM) is -2,264.
From a Technical Analysis Perspective, Is 475830 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Orum Therapeutics Stock Split?
Orum Therapeutics has split 0 times.
What is the current trading status of Orum Therapeutics (475830)?
As of Jul 04, 2026, Orum Therapeutics (475830) is trading at a price of 52,200 KRW, with a previous close of 53,100 KRW. The stock has fluctuated within a day range of 48,950 KRW to 54,100 KRW, while its 52-week range spans from 18,020 KRW to 146,600 KRW.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.